Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC) [abstract 7010] - Gatzemeier,U.PA.; Szczesna,A. (Proc Am Soc Clin Oncol, 2004)